Concepedia

Hua Zhong

HZ

44

Publications

1.6K

Citations

22

H-Index

1998

Active since

Affiliations

Shanghai Chest Hospital(Current)

Shanghai Jiao Tong University

Tianjin Medical University Cancer Institute and Hospital

Henan Cancer Hospital

Zhengzhou University

Hua Zhong is an author at Shanghai Chest Hospital specializing in medicine, lung cancer, and oncology.

ORCID

Top concepts

Publications per year

1998–2025

44

Publications

44

Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC

Tianqing Chu, Runbo Zhong, Hua Zhong et al. · Journal of Thoracic Oncology · 2021 · 216 citations · Full text

, , +6

Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial

Baohui Han, Bo Jin, Tianqing Chu et al. · International Journal of Cancer · 2017 · 152 citations · Full text

Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapy

Jun Lü, Hua Zhong, Tianqing Chu et al. · European Respiratory Journal · 2018 · 94 citations

Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China

Anwen Xiong, Lei Wang, Jianhua Chen et al. · The Lancet · 2025 · 90 citations

, , +6

Schwann Cells Augment Cell Spreading and Metastasis of Lung Cancer

Yan Zhou, Galina V. Shurin, Hua Zhong et al. · Cancer Research · 2018 · 85 citations

Rows per page

1–5 of 44